Carlos Luis Lopez - 30 Jun 2026 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Reporting relationship: SVP, General Counsel
Issuer ticker: NAGE
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jul 2026, 17:18:41 UTC
Prior SEC filing: 24 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeong James Lee, Attorney-in-Fact

Key filing fact

Carlos Luis Lopez filed Form 4 for Niagen Bioscience, Inc. (NAGE) on 08 Jul 2026.

Key facts

This page summarizes Carlos Luis Lopez's Form 4 filing for Niagen Bioscience, Inc. (NAGE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jul 2026, 17:18.

Change

Previous filing in this sequence was filed on 24 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002042509 Primary reporting owner

Lopez Carlos Luis

Relationship: SVP, General Counsel
Address: 10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES
Signature: /s/ Jeong James Lee, Attorney-in-Fact
Signature date: 08 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAGE transaction

Common Stock

Award

Transaction value
Shares: +2,314
Change %: +103%
Price: $2.71^*
Shares after: 4,565
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .